HS014, a selective melanocortin-4 (MC4) receptor antagonist, modulates the behavioral effects of morphine in mice.
BACKGROUND
Melanocortin and opioid systems regulate feeding as well as other behaviors; however, the relationship between the two systems is not yet defined. Since agonist-induced stimulation of melanocortin receptors blocks the behavioral effects of mu opioid receptor agonists, and melanocortin-4 (MC4) receptors and mu opioid receptors share a similar anatomical distribution in the central nervous system, MC4 receptor blockade may increase opioid responsiveness.


OBJECTIVE
The goal of this study was to test the hypothesis that blockade of MC4 receptors increases the behavioral effects of morphine.


METHODS
The effects of HS014 (0.0032, 0.032, and 1 nmol, i.c.v.), a selective MC4 antagonist, on morphine-induced (3.2, 10, and 32 mg/kg, i.p.) locomotor activity (measured in the open field for 15 min) and antinociception (measured in the hot plate at 55 degrees C) were assessed in C57Bl/6 mice. In addition, the effects of morphine were evaluated in A(y) mice, a genetic model for MC4 receptor blockade.


RESULTS
The dose-effect curve of morphine for locomotor activity was shifted downwards in C57Bl/6 mice pretreated with HS014 and in A(y) mice. The dose-effect curve of morphine for antinociception was shifted two- and threefold to the left in C57Bl/6 mice pretreated with HS014 and in A(y) mice, respectively.


CONCLUSIONS
These results indicate that blockade of MC4 receptors increases the antinociceptive effects of morphine without changing the potency of morphine for locomotor activity, suggesting that MC4 receptor antagonists may be candidate drugs that can be clinically used for the treatment of pain.
Ercil
N Eser
NE
Department of Molecular Physiology and Biophysics, Vanderbilt University, 702 Light Hall, Nashville, TN 37232, USA.
Galici
Ruggero
R
Kesterson
Robert A
RA
D000701:Analgesics, Opioid / Q000494:pharmacology*; D000818:Animals; D004305:Dose-Response Relationship, Drug; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009020:Morphine / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects*; D010456:Peptides, Cyclic / Q000494:pharmacology*; D044105:Receptor, Melanocortin, Type 4 / Q000037:antagonists & inhibitors*
D000701:Analgesics, Opioid; C116941:HS014 cyclic peptide; D010456:Peptides, Cyclic; D044105:Receptor, Melanocortin, Type 4; D009020:Morphine
Eur J Pharmacol. 2000 Sep 29;405(1-3):13-24
11033310
Eur J Pharmacol. 1998 Dec 4;362(2-3):95-101
9874158
Eur J Pharmacol. 2001 Oct 19;429(1-3):61-9
11698027
Nature. 1994 Oct 27;371(6500):799-802
7935841
Mol Endocrinol. 1994 Oct;8(10):1298-308
7854347
Cell. 1997 Jan 10;88(1):131-41
9019399
Anesthesiology. 2003 Aug;99(2):449-54
12883419
Br J Anaesth. 2001 Jul;87(1):133-43
11460802
Science. 1992 Aug 28;257(5074):1248-51
1325670
Life Sci. 1997;61(1):1-9
9200663
J Pharmacol Exp Ther. 1984 Apr;229(1):21-6
6323687
J Pain. 2000 Sep;1(3 Suppl):45-50
14622842
Brain Res. 2003 Nov 21;991(1-2):240-4
14575897
Eur J Pharmacol. 2003 Dec 15;482(1-3):127-32
14660013
Eur J Pharmacol. 2002 Jun 20;446(1-3):103-9
12098591
Neuroreport. 2002 Dec 20;13(18):2447-52
12499847
Nature. 1997 Jan 9;385(6612):165-8
8990120
Pain. 1998 Mar;75(1):129-40
9539682
Pharmacol Ther. 2000 Nov;88(2):163-85
11150596
J Pain Symptom Manage. 2001 Apr;21(4):338-54
11312049
Drugs. 1991 Nov;42(5):730-48
1723371
Eur J Pharmacol. 1975 Jun-Jul;32(02):329-36
1171017
Pharmacol Biochem Behav. 1998 Jun;60(2):415-21
9632224
Pharmacol Res. 2000 Nov;42(5):393-420
11023702
Ann Intern Med. 1993 Jul 15;119(2):121-6
8099769
Brain Res. 1990 Jun 25;521(1-2):15-22
2169958
Brain Res. 1985 Dec 23;360(1-2):117-29
3000529
J Pharmacol Exp Ther. 1992 Apr;261(1):311-7
1560376
Peptides. 1981 Summer;2(2):231-3
7291044
J Comp Neurol. 2003 Mar 10;457(3):213-35
12541307
J Pharmacol Exp Ther. 1986 Sep;238(3):997-1003
3018231
Pain. 1990 Feb;40(2):121-9
2308758
Neuropsychopharmacology. 1996 Jun;14(6):375-424
8726752
Br J Anaesth. 1998 Jul;81(1):58-68
9771273
Brain Res. 2000 Dec 29;887(2):460-4
11134642
Pharmacol Biochem Behav. 1998 Feb;59(2):353-60
9476981
J Pharmacol Exp Ther. 1977 May;201(2):368-74
558328
Neuroreport. 1999 Mar 17;10(4):707-11
10208535
Anesth Analg. 2001 Dec;93(6):1572-7, table of contents
11726447
Psychopharmacologia. 1975;41(3):197-200
1153608
Neuropeptides. 1999 Jun;33(3):191-6
10657491
Cell. 1993 Mar 26;72(6):827-34
8458079
Prog Brain Res. 1973;39:383-94
4363914
J Neurosci. 1999 Sep 15;19(18):RC26
10479719
Mol Med Today. 1999 Jun;5(6):250-6
10366820
Psychopharmacologia. 1974;39(1):13-22
4424979
Eur J Pharmacol. 1999 Mar 12;369(1):11-5
10204675
Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8856-60
8415620